TY - JOUR
T1 - Association between Air Quality Index and the risk of rosacea
T2 - a nationwide population-based cohort study
AU - Ma, Sheng Hsiang
AU - Wu, Chun Ying
AU - Li, Meng Chieh
AU - Ho, Hsiu J.
AU - Ao, Chon Kit
AU - Wu, Chen Yi
N1 - Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please cont
PY - 2024/12/23
Y1 - 2024/12/23
N2 - BACKGROUND: Air pollution is associated with several inflammatory skin disorders. However, the association between air quality and rosacea remains unclear. OBJECTIVES: To investigate the association between the Air Quality Index (AQI) and incidence of rosacea. METHODS: In total, 21 709 479 participants without rosacea before 2008 were recruited from the Taiwan National Health Insurance Research Database. The long-term average AQI value for each participant was acquired from the Taiwan Air Quality Monitoring System Network and calculated from 1 January 2008 until the diagnosis of rosacea, withdrawal from the National Health Insurance programme, or 31 December 2018. RESULTS: We observed a significant association between AQI and the incidence of rosacea, with each unit elevation in the AQI increasing the risk of rosacea by 5%. We then categorized participants equally into four groups by quantiles (Q) of AQI values, with mean AQI values of: Q1, 69.0 (SD 6.4); Q2, 79.0 (SD 2.3); Q3, 89.9 (SD 3.6); and Q4, 103.9 (SD 6.8). Compared with the Q1 group, the Q2, Q3 and Q4 cohorts exhibited 1.82-fold, 4.48-fold and 7.22-fold increased risk of rosacea, respectively. Additionally, exposure to particulate matter (PM)2.5 (airborne particulate matter with a diameter ≤ 2.5 μm), sulfur dioxide (SO2) and carbon monoxide increased the risk of rosacea, whereas exposure to PM10 (airborne PM with a diameter ≤ 10 μm) was associated with a lower risk. CONCLUSIONS: This study supported a significant dose-response relationship between AQI and the incidence of rosacea.
AB - BACKGROUND: Air pollution is associated with several inflammatory skin disorders. However, the association between air quality and rosacea remains unclear. OBJECTIVES: To investigate the association between the Air Quality Index (AQI) and incidence of rosacea. METHODS: In total, 21 709 479 participants without rosacea before 2008 were recruited from the Taiwan National Health Insurance Research Database. The long-term average AQI value for each participant was acquired from the Taiwan Air Quality Monitoring System Network and calculated from 1 January 2008 until the diagnosis of rosacea, withdrawal from the National Health Insurance programme, or 31 December 2018. RESULTS: We observed a significant association between AQI and the incidence of rosacea, with each unit elevation in the AQI increasing the risk of rosacea by 5%. We then categorized participants equally into four groups by quantiles (Q) of AQI values, with mean AQI values of: Q1, 69.0 (SD 6.4); Q2, 79.0 (SD 2.3); Q3, 89.9 (SD 3.6); and Q4, 103.9 (SD 6.8). Compared with the Q1 group, the Q2, Q3 and Q4 cohorts exhibited 1.82-fold, 4.48-fold and 7.22-fold increased risk of rosacea, respectively. Additionally, exposure to particulate matter (PM)2.5 (airborne particulate matter with a diameter ≤ 2.5 μm), sulfur dioxide (SO2) and carbon monoxide increased the risk of rosacea, whereas exposure to PM10 (airborne PM with a diameter ≤ 10 μm) was associated with a lower risk. CONCLUSIONS: This study supported a significant dose-response relationship between AQI and the incidence of rosacea.
UR - http://www.scopus.com/inward/record.url?scp=85214318518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85214318518&partnerID=8YFLogxK
U2 - 10.1093/ced/llae291
DO - 10.1093/ced/llae291
M3 - Article
C2 - 39067059
AN - SCOPUS:85214318518
SN - 0307-6938
VL - 50
SP - 69
EP - 76
JO - Clinical and Experimental Dermatology
JF - Clinical and Experimental Dermatology
IS - 1
ER -